CHANTEST, INC.

Company Information
Address 14656 NEO PKY
CLEVELAND, OH, -


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Optimizing the Action Potential of Stem Cell-derived Human Cardiomyocytes for Car

    Amount: $1,184,308.00

    DESCRIPTION (provided by applicant): Stem Cell-derived Human Cardiomyocytes (SC-hCMs) offer great potential for improving the accuracy of pre- clinical cardiac safety testing. We have characterized a ...

    SBIRPhase II2012Department of Health and Human Services
  2. Optimizing the Action Potential of Stem Cell-derived Human Cardiomyocytes for Car

    Amount: $149,275.00

    DESCRIPTION (provided by applicant): Stem Cell-derived Human Cardiomyocytes (SC-hCMs) offer great potential for improving the accuracy of pre-clinical cardiac safety screening. We have recently charac ...

    SBIRPhase I2010Department of Health and Human Services
  3. Development of a Complete Proarrhythmic Safety Profile for Drugs

    Amount: $149,322.00

    DESCRIPTION (provided by applicant): ChanTest's goal is to commercialize a comprehensive non-clinical proarrhythmic profile that will screen compounds through a battery of models that span from the mo ...

    SBIRPhase I2006Department of Health and Human Services
  4. New drugs for treatment of atrial fibrillation

    Amount: $0.00

    DESCRIPTION (provided by applicant): Atrial fibrillation (AF) is the most common cause of arrhythmias in the elderly; it has an incidence of more than 5 percent in people > 69 years of age. At present ...

    SBIRPhase I2003Department of Health and Human Services
  5. New drugs for treatment of atrial fibrillation

    Amount: $580,448.00

    DESCRIPTION (provided by applicant): Atrial fibrillation (AF) is the most common cause of arrhythmias in the elderly; it has an incidence of more than 5 percent in people > 69 years of age. At present ...

    SBIRPhase II2003Department of Health and Human Services
  6. New drugs for treatment of atrial fibrillation

    Amount: $99,924.00

    Atrial fibrillation (AF) is the commonest cardiac arrhythmia and in its chronic form affects more than two million patients in the USA. AF is associated with cardiac and non-cardiac diseases. About 10 ...

    SBIRPhase I2001Department of Health and Human Services
  7. NOVEL SIMPLE SCREEN FOR POTASSIUM CHANNELS

    Amount: $89,263.00

    N/A

    SBIRPhase I1998Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government